These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1306132)

  • 1. Genetic changes in breast carcinomas in an Icelandic population.
    Eyfjörd JE; Thorlacius S
    Pharmacogenetics; 1992 Dec; 2(6):309-16. PubMed ID: 1306132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
    Thorlacius S; Jonasdottir O; Eyfjord JE
    Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
    Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
    Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
    Thorlacius S; Börresen AL; Eyfjörd JE
    Cancer Res; 1993 Apr; 53(7):1637-41. PubMed ID: 8453635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations.
    Børresen AL; Hovig E; Smith-Sørensen B; Malkin D; Lystad S; Andersen TI; Nesland JM; Isselbacher KJ; Friend SH
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8405-9. PubMed ID: 1924299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 abnormalities and genetic instability in breast cancer.
    Eyfjörd JE; Thorlacius S; Valgardsdottir R; Gretarsdottir S; Steinarsdottir M; Anamthawat-Jonsson K
    Acta Oncol; 1995; 34(5):663-7. PubMed ID: 7546836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor genes in breast cancer: an overview.
    Steeg PS
    Cancer Treat Res; 1992; 61():45-57. PubMed ID: 1360244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
    Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
    Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters.
    Thompson AM; Anderson TJ; Condie A; Prosser J; Chetty U; Carter DC; Evans HJ; Steel CM
    Int J Cancer; 1992 Feb; 50(4):528-32. PubMed ID: 1537617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.
    Campo E; Miquel R; Jares P; Bosch F; Juan M; Leone A; Vives J; Cardesa A; Yague J
    Cancer; 1994 Jun; 73(12):2913-21. PubMed ID: 8199988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer.
    Knyazev PG; Imyanitov EN; Chernitsa OI; Nikiforova IF
    Int J Cancer; 1993 Jan; 53(1):11-6. PubMed ID: 8416194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent allelic losses on chromosome 13q in human male breast carcinomas.
    Wingren S; van den Heuvel A; Gentile M; Olsen K; Hatschek T; Söderkvist P
    Eur J Cancer; 1997 Dec; 33(14):2393-6. PubMed ID: 9616288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections.
    Chen T; Dhingra K; Sahin A; Sneige N; Hortobagyi G; Aldaz CM
    Breast Cancer Res Treat; 1996; 39(2):177-85. PubMed ID: 8872326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas.
    Lindblom A; Skoog L; Andersen TI; Rotstein S; Nordenskjöld M; Larsson C
    Hum Genet; 1993 Mar; 91(1):6-12. PubMed ID: 8454289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers.
    Eiriksdottir G; Barkardottir RB; Agnarsson BA; Johannesdottir G; Olafsdottir K; Egilsson V; Ingvarsson S
    Oncogene; 1998 Jan; 16(1):21-6. PubMed ID: 9467939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.
    Cuny M; Kramar A; Courjal F; Johannsdottir V; Iacopetta B; Fontaine H; Grenier J; Culine S; Theillet C
    Cancer Res; 2000 Feb; 60(4):1077-83. PubMed ID: 10706127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic alterations in the region of the p53 gene on human chromosome 17 in colorectal cancer].
    Kashkin KN; Fleĭshman EV; Chumakov PM; Perevoshchikov AG
    Genetika; 1998 Aug; 34(8):1049-55. PubMed ID: 9777351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.
    Thorlacius S; Thorgilsson B; Björnsson J; Tryggvadottir L; Börresen AL; Ogmundsdottir HM; Eyfjörd JE
    Eur J Cancer; 1995 Oct; 31A(11):1856-61. PubMed ID: 8541113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.